AAAAAA
Results:
1-14
|
Results: 14
Authors:
De Pas, T
Curigliano, G
Franceschelli, L
Catania, C
Spaggiari, L
de Braud, F
Citation: T. De Pas et al., Gemcitabine-induced systemic capillary leak syndrome, ANN ONCOL, 12(11), 2001, pp. 1651-1652
Authors:
Paganelli, G
Zoboli, S
Cremonesi, M
Bodei, L
Ferrari, M
Grana, C
Bartolomei, M
Orsi, F
De Cicco, C
Maacke, HR
Chinol, M
de Braud, F
Citation: G. Paganelli et al., Receptor-mediated radiotherapy with Y-90-DOTA-D-Phe(1)-Tyr(3)-octreotide, EUR J NUCL, 28(4), 2001, pp. 426-434
Authors:
Curigliano, G
Ferretti, G
Flamini, G
Goldhirsch, A
de Braud, F
Calabro, MG
Mandaly, M
Nole, F
De Pas, T
D'Addessi, A
Cittadini, A
Citation: G. Curigliano et al., Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradientgel electrophoresis urinalysis, ANTICANC R, 21(4B), 2001, pp. 3015-3020
Authors:
De Pas, T
de Braud, F
Mandala, M
Curigliano, G
Catania, C
Ferretti, G
Sozzi, P
Solli, P
Goldhirsch, A
Citation: T. De Pas et al., Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine, LUNG CANC, 31(2-3), 2001, pp. 267-270
Authors:
Ferretti, G
Curigliano, G
Pastorino, U
Cittadini, A
Flamini, G
Calabro, MG
De Pas, T
Orlando, L
Mandala, M
Colleoni, M
Spaggiari, L
Granone, PL
Pagliari, G
de Braud, F
Fazio, N
Goldhirsch, A
Citation: G. Ferretti et al., Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer, CLIN CANC R, 6(6), 2000, pp. 2393-2400
Authors:
De Pas, T
Curigliano, G
Catania, C
Comandone, A
de Braud, F
Citation: T. De Pas et al., Ifosfamide in the elderly: clinical considerations for a better drug management, CR R ONC H, 33(2), 2000, pp. 129-135
Authors:
De Pas, T
de Braud, F
Danesi, R
Sessa, C
Catania, C
Curigliano, G
Fogli, S
del Tacca, M
Zampino, G
Sbanotto, A
Rocca, A
Cinieri, S
Marrocco, E
Milani, A
Goldhirsch, A
Citation: T. De Pas et al., Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer, ANN ONCOL, 11(7), 2000, pp. 821-827
Authors:
Orlando, L
Colleoni, M
Nole, F
Biffi, R
Rocca, A
Curigliano, G
Ferretti, G
Peruzzotti, G
de Braud, F
Masci, G
Goldhirsch, A
Citation: L. Orlando et al., Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?, ANN ONCOL, 11(1), 2000, pp. 117-118
Authors:
de Gramont, A
Figer, A
Seymour, M
Homerin, M
Hmissi, A
Cassidy, J
Boni, C
Cortes-Funes, H
Cervantes, A
Freyer, G
Papamichael, D
Le Bail, N
Louvet, C
Hendler, D
de Braud, F
Wilson, C
Morvan, F
Bonetti, A
Citation: A. De Gramont et al., Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J CL ONCOL, 18(16), 2000, pp. 2938-2947
Authors:
de Pas, T
Catalano, G
Pastorino, U
de Braud, F
Jereczek-Fossa, B
Spaggiari, L
Orecchia, R
Citation: T. De Pas et al., Very low acute toxicity of three fractions per day accelerated radiotherapy given after induction chemotherapy and surgery in stage III non-small cell lung cancer, LUNG CANC, 30(2), 2000, pp. 149-150
Authors:
Nole, F
Minchella, I
Colleoni, M
Orvieto, E
Munzone, E
de Braud, F
Peruzzotti, G
Martinelli, G
Zampino, MG
Catania, C
Pizzamiglio, M
Veronesi, P
Zurrida, S
Galimberti, V
Goldhirsch, A
Veronesi, U
Citation: F. Nole et al., Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN), ANN ONCOL, 10(8), 1999, pp. 993-996
Authors:
Casali, P
Licitra, L
Tondini, C
de Braud, F
Bruzzi, P
Costa, A
Cavalli, F
Citation: P. Casali et al., START: A European state-of-the-art on-line instrument for clinical oncologists, ANN ONCOL, 10(7), 1999, pp. 769-773
Authors:
Brienza, S
Bensmaine, MA
Soulie, P
Louvet, C
Gamelin, E
Francois, E
Ducreux, M
Marty, M
Andre, T
de Braud, F
Bleiberg, H
Segal, V
Itzhaki, M
Cvitkovic, E
Citation: S. Brienza et al., Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program, ANN ONCOL, 10(11), 1999, pp. 1311-1316
Authors:
Zampino, MG
Colleoni, M
Bajetta, E
Stampino, CG
Guenzi, A
de Braud, F
Citation: Mg. Zampino et al., Pharmacokinetics of oral doxifluridine in patients with colorectal cancer, TUMORI, 85(1), 1999, pp. 47-50
Risultati:
1-14
|